Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC21731 | Letaxaban |
Letaxaban (TAK-442, TAK442) is a potent, selective and direct factor Xa (FXa) inhibitor with Ki of 1.8 nM for hFXa, >440-fold selectivity than thrombin and negligible effects on trypsin, plasmin, and tPA.
More description
|
![]() |
DC23569 | Lesogaberan |
Lesogaberan (AZD-3355) is a potent, selective, peripherally acting GABAB receptor agonist with Ki of 5 nM and EC50 of 8.6 nM, 274-fold selectivity over GABAA (Ki=1.4 uM).
More description
|
![]() |
DC23882 | LEQ 506 |
LEQ 506 (NPV-LEQ 506) is a second-generation inhibitor of Smoothened (Smo) with IC50 of 2 nM and 4 nM for human and mouse Smo, respectively.
More description
|
![]() |
DC12563 | LEM-14-1189 |
LEM-14-1189 is a LEM-14 derivative that differentially inhibits the NSDs with in vitro IC50 of 418 μM (NSD1), IC50 of 111 μM (NSD2) and IC50 of 60 μM (NSD3)..
More description
|
![]() |
DC21231 | LEI-105 |
LEI-105 is a potent, highly selective, and reversible dual DAGL-α/DAGL-β inhibitor with pIC50 pf 7.5/7.4 respectively.
More description
|
![]() |
DCAPI1333 | Leflunomide |
Leflunomide
More description
|
![]() |
DC8775 | LED209 |
LED209 is a potent QseC inhibitor that blocks both norepinephrine- and epinephrine-triggered QseC-dependent virulence gene expression at 5 pM in vitro.
More description
|
![]() |
DC22461 | LDN-76070 |
LDN-76070 is a novel potent SMN2 modulator (EC50=8.3 uM.
More description
|
![]() |
DC22460 | LDN-75654 |
LDN-75654 is a novel potent SMN2 modulator (EC50=1.8 uM.
More description
|
![]() |
DC7452 | LDN-211904 |
LDN-211904 is an inhibitor of erythropoietin-producing hepatocellular carcinoma (Eph) receptors.
More description
|
![]() |
DC22459 | LDN-109657 |
LDN-109657 is a novel SMN2 modulator that increase SMN protein levels in 3813 fibroblasts by twofold at 370 nM..
More description
|
![]() |
DC23787 | LDN 91946 |
LDN 91946 is a selective, uncompetitive ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitor with Ki of 2.8 uM, exhibits no activity against other cysteine hydrolase (UCH-L3, TGase 2, papain and caspase-3)..
More description
|
![]() |
DC21230 | LDK1229 |
LDK1229 is a novel potent, selective cannabinoid CB1 receptor inverse agonist with Ki of 220 nM.
More description
|
![]() |
DC20433 | LDHA-IN-104 |
LDHA-IN-104 is a potent and selective lactate dehydrogenase A (LDHA) inhibitor with IC50 of 0.87 uM, less potent for LDHB (IC50=6.9 uM).
More description
|
![]() |
DC21228 | LDD1937 |
LDD1937 is a novel potent FLT3 inhibitor with IC50 of 3 nM, displays >170-fold selectivity over JAK2/3, c-MET, IRAK-4.
More description
|
![]() |
DC21227 | LCS-1.34 |
LCS-1.34 is a small molecule that inhibits growth of human lung adenocarcinoma cells harboring mutations in EGFR or KRAS with IC50 of 0.1-1.1 uM.
More description
|
![]() |
DC21226 | LCS-1.28 |
LCS-1.28 is a small molecule that inhibits growth of human lung adenocarcinoma cells harboring mutations in EGFR or KRAS with IC50 of 0.05-1.6 uM.
More description
|
![]() |
DC21225 | LCS-1 |
LCS-1 is a small molecule that inhibits growth of human lung adenocarcinoma cells harboring mutations in EGFR or KRAS with IC50 of 0.1-1.5 uM.
More description
|
![]() |
DC9626 | Lck Inhibitor |
Lck Inhibitor is a new class of compounds that are potent inhibitors of Lck with an IC50 value of 7 nM.
IC50 Value: 7 nM [1]
Target: Lck
in vitro: Lck Inhibitor (compound 25) exhibited good potency in the T-cell receptor-induced IL-2 secretion assay (I
More description
|
![]() |
DC21223 | LCB 03-0110 dihydrochloride |
LCB 03-0110 is a potent, ATP-competitive inhibitor of Discoidin domain receptor (DDR) family and c-Src tyrosine kinase family, as well as Btk and Syk.
More description
|
![]() |
DC21222 | LCB 03-0110 |
LCB 03-0110 is a potent, ATP-competitive inhibitor of Discoidin domain receptor (DDR) family and c-Src tyrosine kinase family, as well as Btk and Syk.
More description
|
![]() |
DC22135 | LC-1028 |
LC-1028 (LC1028) is a novel potent selective, covalent and irreversible inhibitor of p97 (valosin-containing protein), remains essentially irreversible ac tivity against p97 mutant C522A..
More description
|
![]() |
DC21221 | LB42908 |
LB42908 is a highly potent, selective, orally active inhibitor of Ras farnesyltransferase (FTase) with IC50 of 0.9 nM against H-Ras and 2.4 nM against K-Ras..
More description
|
![]() |
DC9877 | Lauric Acid |
Lauric Acid is a saturated medium-chain fatty acid with a 12-carbon backbone. Lauric acid is found naturally in various plant and animal fats and oils, and is a major component of coconut oil and palm kernel oil.
More description
|
![]() |
DC12472 | LAS195319 |
LAS195319 (LAS-195319) is a potent, selective, inhaled PI3Kδ inhibitor with IC50 of 0.5 nM, weakly inhibits PI3Kβ and γ (>20-fold), no activity against PI3Kα.
More description
|
![]() |
DCAPI1019 | L-Arginine HCl |
L-Arginine is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis.
More description
|
![]() |
DC9433 | Lapatinib (ditosylate) |
Lapatinib ditosylate(GW-572016 ditosylate) is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.
More description
|
![]() |
DC9091 | Lansoprazole |
Lansoprazole(AG 1749) is a proton pump inhibitor which prevents the stomach from producing acid.
More description
|
![]() |
DC23824 | Lanperisone |
Lanperisone (NK 433) is a centrally acting muscle relaxant that selectively kills of K-ras mutant cancer cells in a cell cycle-independent fashion.
More description
|
![]() |
DCAPI1463 | Landiolol Hydrochloride |
Landiolol Hydrochloride
More description
|
![]() |